Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

AGEN | Agenus Inc

Index	RUT	P/E	-	EPS (ttm)	-0.84	Insider Own	2.46%	Shs Outstand	379.57M	Perf Week	-13.68%
Market Cap	383.37M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	370.25M	Perf Month	-21.09%
Income	-262.80M	PEG	-	EPS next Q	-0.20	Inst Own	55.00%	Short Float / Ratio	7.90% / 7.24	Perf Quarter	-35.67%
Sales	99.36M	P/S	3.86	EPS this Y	1.05%	Inst Trans	8.26%	Short Interest	29.25M	Perf Half Y	-30.92%
Book/sh	-0.25	P/B	-	EPS next Y	8.86%	ROA	-62.54%	Target Price	7.66	Perf Year	-50.75%
Cash/sh	0.42	P/C	2.43	EPS next 5Y	-	ROE	-1998.16%	52W Range	1.02 - 3.31	Perf YTD	-57.11%
Dividend	-	P/FCF	-	EPS past 5Y	8.66%	ROI	-174.18%	52W High	-69.46%	Beta	1.38
Dividend %	-	Quick Ratio	0.84	Sales past 5Y	84.19%	Gross Margin	80.19%	52W Low	-0.98%	ATR	0.08
Employees	533	Current Ratio	0.84	Sales Q/Q	20.88%	Oper. Margin	-210.03%	RSI (14)	26.69	Volatility	6.40% 6.25%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-17.16%	Profit Margin	-264.50%	Rel Volume	0.68	Prev Close	1.03
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 08 BMO	Payout	-	Avg Volume	4.04M	Price	1.01
Recom	1.17	SMA20	-15.94%	SMA50	-23.31%	SMA200	-41.83%	Volume	2,743,421	Change	-1.94%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-06-23	Initiated	Robert W. Baird	Outperform	$8
Jun-06-23	Initiated	Robert W. Baird	Outperform	$60 → $80
Feb-28-23	Resumed	H.C. Wainwright	Buy	$8
Sep-28-22	Initiated	SMBC Nikko	Outperform	$5
Dec-16-21	Initiated	H.C. Wainwright	Buy	$12
Nov-19-19	Resumed	B. Riley FBR	Buy	$6
Apr-22-19	Initiated	B. Riley FBR	Buy
Oct-28-16	Downgrade	H.C. Wainwright	Buy → Neutral	$10 → $5
Oct-27-16	Reiterated	Maxim Group	Buy
Mar-11-16	Upgrade	Maxim Group	Hold → Buy	$7
Dec-16-15	Initiated	Jefferies	Buy
Oct-27-15	Downgrade	Maxim Group	Buy → Hold
Jul-27-15	Reiterated	MLV & Co	Buy	$9 → $11
Jun-11-15	Initiated	Oppenheimer	Outperform	$14
Jan-12-15	Reiterated	Maxim Group	Buy	$10 → $11
Jan-09-15	Reiterated	MLV & Co	Buy	$6 → $9
Jan-09-15	Reiterated	Maxim Group	Buy	$10 → $11
Dec-19-14	Reiterated	Maxim Group	Buy	$8 → $10
May-08-14	Reiterated	Maxim Group	Buy	$17 → $11
Mar-14-14	Reiterated	MLV & Co	Buy	$9 → $11

Show Previous Ratings

Sep-01-23 04:30PM	Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-28-23 08:30AM	3 Magnificent Growth Stocks to Buy on the Dip (Motley Fool) +5.34%
07:30AM	Agenus to Participate in September Investor Conferences (Business Wire)
Aug-24-23 09:54AM	Agenus (AGEN) to Focus on BOT/BAL Candidate, Stock Falls 7% (Zacks)
Aug-23-23 02:00PM	Watertown biotech shares spike after accidental data publication at Roche (American City Business Journals) -7.28%
01:16PM	Loading…
01:16PM	Lexington biotech lays off 91 as it narrows focus (American City Business Journals)
08:00AM	Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers (Business Wire)
Aug-18-23 04:27AM	Q2 2023 Xilio Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +11.36%
Aug-17-23 10:04AM	Billionaire Steve Cohen Loads Up on These 2 Strong Buy Penny Stocks Heres Why Wall Street Sees Over 500% Upside Potential (TipRanks)
Aug-09-23 08:30AM	SaponiQx Announces Breakthrough in Scaling Up of STIMULON Cultured Plant Cell Adjuvant (Business Wire)
Aug-08-23 10:00AM	Compared to Estimates, Agenus (AGEN) Q2 Earnings: A Look at Key Metrics (Zacks) -8.09%
08:19AM	Agenus: Q2 Earnings Snapshot (AP Finance)
07:30AM	Agenus Reports Second Quarter 2023 Results (Business Wire)
Aug-03-23 05:25PM	Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-28-23 07:30AM	Agenus Botensilimab/Balstilimab Data Update in Sarcomas Selected for Oral Presentation at ESMO 2023 (Business Wire) +5.52%
07:30AM	Loading…
Jul-26-23 07:30AM	Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update (Business Wire)
Jul-20-23 07:30AM	Agenus Expands Executive Leadership Team (Business Wire)
Jul-10-23 07:58AM	With 52% institutional ownership, Agenus Inc. (NASDAQ:AGEN) is a favorite amongst the big guns (Simply Wall St.) +10.98%
Jun-30-23 11:15AM	ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer (Business Wire)
Jun-26-23 10:15AM	2 Low-Priced Stocks That Could Make You Richer (Motley Fool) -5.20%
Jun-06-23 07:46AM	Even after rising 19% this past week, Agenus (NASDAQ:AGEN) shareholders are still down 53% over the past three years (Simply Wall St.) +6.94%
Jun-05-23 09:49AM	Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO (Business Wire) +8.12%
07:30AM	Agenus Announces Virtual Annual Shareholders Meeting (Business Wire)
May-25-23 07:30AM	Agenus to Participate in Jefferies Healthcare Conference (Business Wire)
May-10-23 06:11AM	Broker Revenue Forecasts For Agenus Inc. (NASDAQ:AGEN) Are Surging Higher (Simply Wall St.)
May-09-23 07:00PM	Agenus (AGEN) Q1 2023 Earnings Call Transcript (Motley Fool) -5.66%
09:15AM	Agenus (AGEN) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
08:10AM	Agenus: Q1 Earnings Snapshot (AP Finance)
08:00AM	Agenus Provides Corporate Update and First Quarter 2023 Financial Results (Business Wire)
May-03-23 09:08AM	Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI (Business Wire) +5.67%
10:35AM	Loading…
Apr-26-23 10:35AM	Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting (Business Wire)
Apr-25-23 07:30AM	Agenus to Provide Corporate Update and First Quarter 2023 Financial Report (Business Wire) -5.75%
Apr-24-23 07:30AM	Agenus to Participate in May Investor Conferences (Business Wire)
Apr-18-23 11:20AM	Agenus (AGEN) Rises on Fast Track Tag for Cancer Combo Drug (Zacks)
Apr-17-23 01:55PM	These 3 Nasdaq Stocks Are on Fire Today: Here's Why (Motley Fool) +15.86%
08:47AM	Lacklustre Performance Is Driving Agenus Inc.'s (NASDAQ:AGEN) Low P/S (Simply Wall St.)
07:30AM	Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer (Business Wire)
Apr-12-23 04:30PM	Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer (GlobeNewswire)
Apr-04-23 03:53PM	Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today (Motley Fool) -5.10%
Mar-30-23 08:41AM	Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics (Business Wire) -7.05%
Mar-27-23 03:12PM	Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer (Benzinga)
09:45AM	Agenus Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer (Business Wire)
Mar-23-23 12:21PM	Why Agenus Stock Is Slumping This Week (Motley Fool)
Mar-17-23 04:31AM	Agenus Inc. (NASDAQ:AGEN) Q4 2022 Earnings Call Transcript (Insider Monkey) -7.10%
Mar-14-23 04:00PM	Agenus (AGEN) Q4 2022 Earnings Call Transcript (Motley Fool)
08:45AM	Agenus (AGEN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives (GlobeNewswire)
Mar-12-23 08:29PM	Agenus Cancels Conference Call to Discuss the Companys Minority Cash Holdings at SVB in Light of Governments SVB Deposit Access Announcement (GlobeNewswire)
Mar-11-23 11:24AM	Agenus Schedules Conference Call to Discuss the Companys Minority Cash Holdings at SVB (GlobeNewswire)
Feb-28-23 07:30AM	Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report (GlobeNewswire)
07:30AM	Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Womens Cancer (GlobeNewswire)
Jan-31-23 06:20AM	Agenus Inc. (NASDAQ:AGEN) is definitely on the radar of institutional investors who own 46% of the company (Simply Wall St.)
Jan-26-23 07:30AM	Agenus to Participate in February Investor Conferences (GlobeNewswire)
Jan-23-23 02:33PM	Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate (Benzinga) -5.56%
07:30AM	Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI (GlobeNewswire)
Jan-18-23 11:11AM	2 Momentum Trades Showing Worst to First Action (TheStreet.com)
Jan-10-23 08:30AM	Agenus to Participate at B Riley Securities 2023 Virtual Oncology Conference (GlobeNewswire) +11.39%
Dec-28-22 10:39AM	12 Best Biotech Stocks to Buy Under $10 (Insider Monkey) -6.47%
Dec-21-22 10:59AM	Agenus (NASDAQ:AGEN shareholders incur further losses as stock declines 12% this week, taking three-year losses to 42% (Simply Wall St.)
08:30AM	Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI (GlobeNewswire)
Dec-19-22 12:55PM	7 Hot Stocks to Book Profits In Before 2023 (InvestorPlace)
Dec-02-22 04:47PM	Why Shares of Agenus Rose 12.5% on Friday (Motley Fool) +12.50%
Nov-17-22 08:30AM	Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma (GlobeNewswire)
Nov-16-22 08:30AM	Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-14-22 08:30AM	Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers (GlobeNewswire) +16.73%
Nov-10-22 06:02AM	Agenus Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.) +21.29%
Nov-08-22 02:00PM	Agenus (AGEN) Q3 2022 Earnings Call Transcript (Motley Fool) -6.69%
09:25AM	Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Agenus Provides Corporate Update and Third Quarter 2022 Financial Report (GlobeNewswire)
Oct-31-22 05:50PM	Agenus (AGEN) Dips More Than Broader Markets: What You Should Know (Zacks)
Oct-26-22 10:11AM	Agenus (AGEN) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-25-22 05:50PM	Agenus (AGEN) Gains But Lags Market: What You Should Know (Zacks)
08:30AM	Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report (GlobeNewswire)
Oct-24-22 06:00PM	Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know (Zacks)
Oct-18-22 06:00PM	Agenus (AGEN) Outpaces Stock Market Gains: What You Should Know (Zacks)
Oct-13-22 11:23AM	VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study (Zacks)
08:32AM	GSKs older adult RSV vaccine candidate, containing Agenus QS-21 STIMULON, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial (GlobeNewswire)
Oct-12-22 10:38AM	VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy (Benzinga)
08:00AM	VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients (GlobeNewswire)
Oct-10-22 06:00PM	Agenus (AGEN) Dips More Than Broader Markets: What You Should Know (Zacks)
Oct-06-22 04:50PM	Why Agenus Stock Rose 18.4% on Thursday (Motley Fool) +18.14%
Oct-05-22 08:30AM	Agenus to Host The Road Taken R&D Event on November 12, 2022 (GlobeNewswire) +7.24%
08:00AM	Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (GlobeNewswire)
Sep-30-22 05:50PM	Agenus (AGEN) Stock Moves -0.49%: What You Should Know (Zacks)
09:00AM	Here is What to Know Beyond Why Agenus Inc. (AGEN) is a Trending Stock (Zacks)
Sep-28-22 09:31AM	Bet on These 4 Biotech Stocks With Bright Prospects (Zacks) +7.84%
Sep-26-22 11:17AM	AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication (Zacks) -7.98%
Sep-23-22 11:14AM	Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris (Zacks)
Sep-19-22 05:50PM	Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:00AM	Is Trending Stock Agenus Inc. (AGEN) a Buy Now? (Zacks)
Sep-15-22 12:15PM	J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up (Zacks)
Sep-14-22 01:33PM	Key Factors Driving Merck's (MRK) Outperformance This Year (Zacks)
Sep-12-22 12:22PM	Pfizer (PFE) Alopecia Drug Filings Get Accepted by FDA, EMA (Zacks)
08:30AM	Agenus Makes Senior Regulatory and Clinical Appointments (GlobeNewswire)
08:30AM	Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials in Advanced MSS Colorectal Cancer and Advanced Melanoma (GlobeNewswire)
Sep-08-22 09:37AM	Pfizer (PFE) Streptococcus Jab Gets FDA's Breakthrough Tag (Zacks)
Sep-07-22 11:40AM	GSK's NDA for Daprodustat to be Reviewed by an FDA Panel (Zacks)
Sep-06-22 11:09AM	AstraZeneca (AZN) Imfinzi Gets FDA Nod for Biliary Tract Cancer (Zacks) -5.84%
09:00AM	Is Most-Watched Stock Agenus Inc. (AGEN) Worth Betting on Now? (Zacks)
Sep-05-22 01:05PM	Vertex (VRTX) CF Drug Gets FDA Expanded Label for Toddlers (Zacks)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AGENUS INC	10% Owner	Aug 29	Buy	1.52	29,678	45,016	21,734,887	Aug 31 05:53 PM
AGENUS INC	10% Owner	Aug 28	Buy	1.45	12,808	18,570	21,705,209	Aug 28 05:15 PM
AGENUS INC	10% Owner	Aug 24	Buy	1.54	170,244	262,908	21,692,401	Aug 28 05:15 PM
AGENUS INC	10% Owner	May 11	Buy	1.43	23,361	33,348	21,640,473	May 12 05:18 PM
AGENUS INC	10% Owner	May 10	Buy	1.51	22,065	33,296	21,617,112	May 12 05:18 PM
AGENUS INC	10% Owner	May 05	Buy	0.95	100,200	95,100	21,595,047	May 05 06:00 PM
AGENUS INC	10% Owner	May 04	Buy	1.22	21,473	26,246	21,494,847	May 05 06:00 PM
AGENUS INC	10% Owner	May 03	Buy	1.08	128,689	138,843	21,473,374	May 05 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AGEN | Agenus Inc

Upgrade your FINVIZ experience